Northern Trust’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-335,539
| Closed | -$6.02M | – | 4322 |
|
|
2017
Q4 | $6.02M | Sell |
335,539
-7,906
| -2% | -$97.3K | ﹤0.01% | 2491 |
|
|
2017
Q3 | $4.05M | Buy |
343,445
+278
| +0.1% | +$3.12K | ﹤0.01% | 2760 |
|
|
2017
Q2 | $3.6M | Buy |
343,167
+37,749
| +12% | +$385K | ﹤0.01% | 2822 |
|
|
2017
Q1 | $3.36M | Buy |
305,418
+3,834
| +1% | +$44.5K | ﹤0.01% | 2799 |
|
|
2016
Q4 | $4.09M | Sell |
301,584
-6,182
| -2% | -$86.2K | ﹤0.01% | 2674 |
|
|
2016
Q3 | $3.79M | Buy |
307,766
+15,374
| +5% | +$181K | ﹤0.01% | 2702 |
|
|
2016
Q2 | $3.21M | Sell |
292,392
-34,155
| -10% | -$382K | ﹤0.01% | 2752 |
|
|
2016
Q1 | $3.57M | Buy |
326,547
+21,600
| +7% | +$273K | ﹤0.01% | 2633 |
|
|
2015
Q4 | $5.27M | Buy |
304,947
+10,148
| +3% | +$182K | ﹤0.01% | 2436 |
|
|
2015
Q3 | $5.86M | Buy |
294,799
+65,377
| +28% | +$1.5M | ﹤0.01% | 2346 |
|
|
2015
Q2 | $3.77M | Buy |
229,422
+14,332
| +7% | +$249K | ﹤0.01% | 2694 |
|
|
2015
Q1 | $3.35M | Sell |
215,090
-3,098
| -1% | -$48K | ﹤0.01% | 2775 |
|
|
2014
Q4 | $3.12M | Sell |
218,188
-4,757
| -2% | -$50.2K | ﹤0.01% | 2801 |
|
|
2014
Q3 | $1.45M | Buy |
222,945
+31,598
| +17% | +$210K | ﹤0.01% | 3283 |
|
|
2014
Q2 | $1.32M | Sell |
191,347
-12,032
| -6% | -$85.1K | ﹤0.01% | 3289 |
|
|
2014
Q1 | $1.45M | Sell |
203,379
-18,206
| -8% | -$156K | ﹤0.01% | 3277 |
|
|
2013
Q4 | $2.08M | Sell |
221,585
-7,352
| -3% | -$52.4K | ﹤0.01% | 3129 |
|
|
2013
Q3 | $1.43M | Sell |
228,937
-3,052
| -1% | -$19.1K | ﹤0.01% | 3234 |
|
|
2013
Q2 | $1.53M | Buy |
+231,989
| New | +$1.84M | ﹤0.01% | 3125 |
|
Other funds holding SCMP
Northern Trust's SCMP Position: Q1 2018 in Review
Northern Trust sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 335,539 shares — an estimated $6.02M sold.
Northern Trust first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $6.02M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Northern Trust reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Northern Trust sold 335,539 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $6.02M.
- Northern Trust first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Northern Trust's Sucampo Pharmaceuticals, Inc. position peaked at $6.02M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.